Allogene Therapeutics shares owned by Brevan Howard Capital Management
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Brevan Howard Capital Management
from 13F filings
Historical chart of Brevan Howard Capital Management investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Allogene Therapeutics by Brevan Howard Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $152k | 62k | 2.44 |
| 2025-12-31 | $97k | 70k | 1.37 |
| 2025-06-30 | $93k | 82k | 1.13 |
| 2025-03-31 | $359k | 246k | 1.46 |
| 2024-12-31 | $187k | 88k | 2.13 |
| 2024-09-30 | $177k | 63k | 2.80 |
| 2024-06-30 | $139k | 60k | 2.33 |
| 2024-03-31 | $144k | 32k | 4.47 |
| 2023-12-31 | $315k | 98k | 3.21 |
| 2023-09-30 | $58k | 18k | 3.17 |
More positions owned by Brevan Howard Capital Management
View all positions for Brevan Howard Capital Management